[1]
Jørgensen, C.L.T. et al. 2014. PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients. Acta Oncologica. 53, 6 (Jun. 2014), 776–787. DOI:https://doi.org/10.3109/0284186X.2013.865076.